Conversely, in a mouse model of adoptive T-cell cancer therapy, tumor-specific CD8+ T cells unable to shed L-selectin were better able to restrict the growth of solid and disseminated tumors than WT T cells (13). The gene discussed is CD8A; the disease is neoplasm.